Mycoplasma hyopneumoniae: recent development

DR Dominiek Maes - Ceva Forum 2018

North America
- Canada ENGLISH
- United States ENGLISH
Latin America
- Argentina ESPAÑOL
- Brazil PORTUGUÊS
- Mexico ESPAÑOL
- Perú ESPAÑOL
Global
- CEVA Global ENGLISH | FRANÇAIS
Europe
- Belgium NEDERLANDS | FRANÇAIS
- Denmark DANSK
- France FRANÇAIS
- Germany DEUTSCH
- Italy ITALIANO
- Netherlands NEDERLANDS
- Portugal PORTUGUÊS
- Spain ESPAÑOL
- Sweden SVENSK
- United Kingdom ENGLISH
EMEA (Regional)
- Africa ENGLISH | FRANÇAIS
- Bulgaria БЪЛГАРСКИ
- Egypt ENGLISH
- Greece ΕΛΛΗΝΙΚΑ
- Hungary MAGYAR | ENGLISH
- Poland POLSKI
- Romania ROMÂNĂ | ENGLISH
- Russia РУССКИЙ
- South Africa AFRIKAANS | ENGLISH
- Tunisia FRANÇAIS
- Turkey TÜRKÇE
- Ukraine UKRAINIAN
Asia Pacific
- Asia Pacific (Regional) English
- China 中文
- India ENGLISH
- Indonesia BAHASA INDONESIA
- Japan 日本語
- Korea 한국어
- Malaysia ENGLISH
- Philippines ENGLISH
- Vietnam TIẾNG VIỆT | ENGLISH

Warning message

These pages are not intended for users based in France.

To access information for French residents, please visit the dedicated website: https://www.ceva-santeanimale.fr

Further, product information presented on these pages may be used by authorized professionals in the veterinary field only and/or may not be available in certain countries and are always subject to local regulatory requirements.

These pages are general information pages. No guarantee is given as to the completeness of the information contained or its compliance with national regulatory requirements. Users should consult the local site of their countries to obtain information that complies with applicable national regulations.

Mycoplasma hyopneumoniae: recent development

See also